QIAGEN Gaithersburg

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, QIAGEN Gaithersburg sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 7 completed top decile by trial count

QIAGEN Gaithersburg: 11 sponsored US clinical trials, none currently recruiting.

QIAGEN Gaithersburg sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. The most-studied condition in this pipeline is Cytomegalovirus Infections, with 1 trials.

Top-decile sponsor footprint

QIAGEN Gaithersburg ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

7 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (63.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

11 total, page 1 of 1

TERMINATED

Clinical Evaluation of the QuantiFERON CMV Assay

NCT03502161
COMPLETED

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

NCT02687529
TERMINATED

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

NCT02416414
COMPLETED

Evaluation of the QuantiFERON-TB Test.

NCT02253537
COMPLETED

Evaluation of the QuantiFERON-TB Test.

NCT02256839
COMPLETED

Evaluation of the QuantiFERON-TB Test.

NCT02142894
TERMINATED

Clinical Evaluation of the AmniSure ROM Test

NCT01847820
TERMINATED

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People

NCT01904201
COMPLETED

Collection and Testing of Respiratory Samples

NCT01302418
COMPLETED

Collection and Extraction of Respiratory Specimens

NCT01083511
COMPLETED

Evaluation of the Artus® CMV PCR Test

NCT01034709

Therapeutic Areas

Cytomegalovirus Infections 1
Tuberculosis 1

How the QIAGEN Gaithersburg archive is shaped

11 indexed studies, none listed as recruiting (0% open); 7 completed (64%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cytomegalovirus Infections (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

QIAGEN Gaithersburg: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

QIAGEN Gaithersburg sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share QIAGEN GaithersburgAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
QIAGEN Gaithersburg sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

QIAGEN Gaithersburg sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this QIAGEN Gaithersburg page

11 registered trials is a research-attention snapshot, not an endorsement of QIAGEN Gaithersburg or any single study.

  • None of QIAGEN Gaithersburg's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cytomegalovirus Infections is the condition QIAGEN Gaithersburg studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cytomegalovirus Infections trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. QIAGEN Gaithersburg pipeline card: 11 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.